Josh ZeidmanSenior Vice President, Business Development at PHILSpeaker
Profile
Josh is the SVP of Business Development at PHIL where he is focused on bringing patient access and distribution solutions to pharmaceutical companies across the United States. With PHIL's digitally-enabled hub and direct-to-patient solutions, pharma brands can improve patient access, affordability, and adherence while maximizing gross-to-net impact. Josh and his team partner closely with retail and specialty-lite brands to design optimized alternative channels that help patients get on therapy easier and faster.
Josh has over 10 years of experience working directly with major pharmaceutical partners. Prior to joining PHIL, he has led BD teams across the digital health tech space and worked as a consultant at BCG serving global pharma clients. He holds a degree in chemical engineering from MIT.
Agenda Sessions
Direct-to-Patient Strategy—When to Use It and How to Integrate It with Traditional Channels
, 1:45pmView Session